Celularity faces Nasdaq suspension Oct 25 for delinquent 10-Q filings; plans appeal

Celularity Inc

Nasdaq notified Celularity on Oct 16, 2024, that trading will be suspended Oct 25 due to failure to file Q1 and Q2 2024 10-Qs by Oct 14 extension deadline.
Celularity intends to appeal Nasdaq's determination by Oct 23, 2024, under Listing Rule 5800 Series.
If appeal is filed, trading continues during appeal process; no assurance of success in regaining compliance.
Previously, on Aug 22, 2024, Nasdaq notified Celularity of non-compliance; exception granted until Oct 14, but forms still not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.